KOLIBRI is an early-stage deep-tech biotech start-up company that unlocks the potential of gene therapies and next-generation vaccines. It aims to make large-scale viral vector manufacturing cheaper and faster by combining cutting-edge techniques in chemical optimization and acoustics. The company was founded n 2020.

Paris, France

KOLIBRI

Ambitious individuals leave places like Google, Goldman Sachs and Stanford to join EF. Why? Because starting a startup is the highest impact thing you can do with your life.    EF is the best place to find a co-founder, build a company and access the world's best investors. We've helped build over 80 technology companies, collectively worth over $1bn.
EF is backed by Reid Hoffman (founder of LinkedIn) and Greylock Partners, Mosaic Ventures, Founders Fund, Lakestar and some of the world's best entrepreneurs.
Read our manifesto here.

Join aworld-changingstartup

Join a
world-changing
startup